ACW - the run beginning..., page-10

Have taken a position here over the past few weeks via a ACWOB entry and have bought a significant amount of them. Yes some say they might be going through at a premium but if you want a significant amount of them you are not going to get them fiddling around trying to pick them up on the cheap. I dont sit in ques waiting for an entry and these even though at a slight premium i believe offer seriously huge leverage on a stock that is significantly undervalued to its peers in the Alzheimers's space globally. For a biotech currently in phs 2 studies for a drug in a significant space like Alzheimer's this is dirt cheap and offers huge upside as the market awakens to its current undervalued cap as they progress trials in a disease that is crying out for new treatments in a massive market.

Alzheimer's is a global problem that is increasing and the cost of care for sufferers is increasing yearly and there is a huge need for new treatments. Xnamem in current phs 2 studies should see it a a significantly higher market cap on the potential of it alone with others in the sector globally having market caps significantly higher at similar stage. I believe the market is finally waking up to Actinogens potential and we will see a significant rise in 2018 bringing the stock price in line with its peers. ACW has a strong board with Bill Ketelbey leading the way with his own experience with Pfizer and the current lead Alzheimer's drug Aricept. I believe with his role and past with Pfizer that Pfizer will be watching Actinogen's trials very closely as they progress. The recent addition to the board also of ex Amgen executive Dr George Morstyn is another tick to the quality of the board of ACW. He also brings a wealth of experience while at Amgen in drug development and new drug launches in his time.

With the market being heavy in Lithium and battery metals through the past few years and recently blockchain we have seen biotech's get little interest but i feel its time to add some quality high potential bios now. ACW through ACWOB is my play in the bio space in 2018.